OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurogenic inflammation and its role in migraine
Roshni Ramachandran
Seminars in Immunopathology (2018) Vol. 40, Iss. 3, pp. 301-314
Closed Access | Times Cited: 253

Showing 51-75 of 253 citing articles:

Microglia-Astrocyte Cross Talk through IL-18/IL-18R Signaling Modulates Migraine-like Behavior in Experimental Models of Migraine
Qiaoyu Gong, Yao Lin, Zuneng Lu, et al.
Neuroscience (2020) Vol. 451, pp. 207-215
Closed Access | Times Cited: 37

Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment
Parisa Gazerani
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 6, pp. 681-694
Closed Access | Times Cited: 36

Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial
Zeinab Ghorbani, Mansoureh Togha, Pegah Rafiee, et al.
Neurological Sciences (2020) Vol. 41, Iss. 5, pp. 1183-1192
Closed Access | Times Cited: 36

Relationship between migraine headache and hematological parameters
Gülhan SARIÇAM
Acta Neurologica Belgica (2020) Vol. 121, Iss. 4, pp. 899-905
Closed Access | Times Cited: 35

Effects of estrogen and progesterone on the neurogenic inflammatory neuropeptides: implications for gender differences in migraine
Ayhan Çetinkaya, Erkan Kılınç, Çağrı Çamsarı, et al.
Experimental Brain Research (2020) Vol. 238, Iss. 11, pp. 2625-2639
Closed Access | Times Cited: 35

The trigeminal system: The meningovascular complex— A review
Louis‐Marie Terrier, Nouchine Hadjikhani, Stéphane Velut, et al.
Journal of Anatomy (2021) Vol. 239, Iss. 1, pp. 1-11
Open Access | Times Cited: 28

Experimental and Clinical Evidence of the Effectiveness of Riboflavin on Migraines
Gaku Yamanaka, Shinji Suzuki, Natsumi Morishita, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2612-2612
Open Access | Times Cited: 27

DNA Damage and Repair in Migraine: Oxidative Stress and Beyond
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22

Migraine as an inflammatory disorder with microglial activation as a prime candidate
Amrit Sudershan, Mohd Younis, Srishty Sudershan, et al.
Neurological Research (2022) Vol. 45, Iss. 3, pp. 200-215
Closed Access | Times Cited: 19

Glia Signaling and Brain Microenvironment in Migraine
Hanieh Amani, Alireza Soltani Khaboushan, Gisela M. Terwindt, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3911-3934
Closed Access | Times Cited: 12

Targeting Glutamate Neurotoxicity through Dietary Manipulation: Potential Treatment for Migraine
Fahimeh Martami, Kathleen F. Holton
Nutrients (2023) Vol. 15, Iss. 18, pp. 3952-3952
Open Access | Times Cited: 12

Essential oil from Ligusticum chuanxiong Hort. Alleviates lipopolysaccharide-induced neuroinflammation: Integrating network pharmacology and molecular mechanism evaluation
Jing Zuo, Tianhao Zhang, Cheng Peng, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117337-117337
Closed Access | Times Cited: 12

OnabotulinumtoxinA: Still the Present for Chronic Migraine
Carlo Baraldi, Flavia Lo Castro, Raffaele Ornello, et al.
Toxins (2023) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 11

Tear neuropeptides are associated with clinical symptoms and signs of dry eye patients
Yirou Zhang, Hong Zhang, Xingyu Zhu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access

Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine
Caroline Machado Kopruszinski, John E. Linley, Peter Thornton, et al.
Brain (2025)
Closed Access

Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
Vaishali Naik, Ravi Uniyal, Ravindra Kumar Garg, et al.
Headache The Journal of Head and Face Pain (2025)
Closed Access

Revisiting Migraine Pathophysiology: from Neurons To Immune Cells Through Lens of Immune Regulatory Pathways
Sugumar Subalakshmi, Rapuru Rushendran, Chitra Vellapandian
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access

The association between migraine and gut microbiota: a systematic review
Alon Gorenshtein, Kamel Shihada, Liron Leibovitch, et al.
Acta Neurologica Belgica (2025)
Open Access

High-risk area for migraine attacks — a new concept in migraine pathophysiology
Marianna Gabriella Rispoli, Maria Vittoria De Angelis, Donato Melchionda, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access

Novelty in Inflammation and Immunomodulation in Migraine
Cinzia Cavestro, Marcella Ferrero, Silvia Mandrino, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 27, pp. 2919-2936
Closed Access | Times Cited: 35

Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine
Salvo Danilo Lombardo, Emanuela Mazzon, Maria Sofia Basile, et al.
Brain Sciences (2019) Vol. 9, Iss. 7, pp. 172-172
Open Access | Times Cited: 32

Receptor mechanisms mediating the anti‐neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine
Erkan Kılınç, Seyit Ankaralı, İbrahim Ethem Torun, et al.
European Journal of Neuroscience (2020) Vol. 55, Iss. 4, pp. 1015-1031
Closed Access | Times Cited: 29

Scroll to top